Additionally, an analysis of the loss-of-function and gain-of-function models revealed the influence of SATB1′s expression on bladder cancer cell proliferation, migration, apoptosis and sensitivity to cisplatin-based chemotherapy [44,69,122]. Here, SATB1 is linked to urinary bladder carcinoma.